Lv1
50 积分 2023-11-10 加入
An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response for B7 family using multi-omics data
2天前
已完结
Current landscape of CD3 bispecific antibodies in hematologic malignancies
2天前
已完结
Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies
5天前
已完结
Targeting the tumour vasculature: from vessel destruction to promotion
12天前
已完结
First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of DS‐7011a, an Anti‐TLR7 Antagonistic Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
16天前
已完结
POS1320 FUNCTIONAL MAPPING OF AUTOIMMUNE PATIENTS BASED ON SERUM IMMUNE COMPLEXES REVEALS A COMMON TLR7/8 ENDOTYPE
16天前
已关闭
The present and future of bispecific antibodies for cancer therapy
16天前
已完结
Progressive polyadenylation and m6A modification of Ighg1 mRNA maintain IgG1 antibody homeostasis in antibody-secreting cells
29天前
已完结
Exploring the Role of Target Expression in Treatment Efficacy of Antibody–Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
1个月前
已完结
Antibody-drug conjugates for targeted cancer therapy: recent advances in potential payloads
1个月前
已完结
皖公网安备34019202002308
